Kelly CRISPR & Gene Editing Technology ETF (XDNA) News Today

$7.38
0.00 (0.00%)
(As of 05/17/2024 ET)
Gene editing is now a medical reality
3 Biotech Stocks That Are Betting on the Future of Gene Editing
Kelly CRISPR & Gene Editing Technology ETF (XDNA)
Megatrends: Gene Therapy and Editing
Genome Editing Technologies Market Report 2022-2032
Unlocking the Potential of Gene Editing
3 Sectors You Might Have Missed with Upside (XDNA)
Thematic ETFs are poised to become more important vehicles for accessing subindustries in very targeted ways that are not possible with broad sector funds.
Get Kelly CRISPR & Gene Editing Technology ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for XDNA and its competitors with MarketBeat's FREE daily newsletter.

Next President (Not Trump. Not Biden.) (Ad)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.

XDNA Media Mentions By Week

XDNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XDNA
News Sentiment

0.80

0.70

Average

News Sentiment

XDNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XDNA Articles
This Week

1

0

XDNA Articles
Average Week

Get Kelly CRISPR & Gene Editing Technology ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for XDNA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
This page (NASDAQ:XDNA) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners